Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers

  • Read more about Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers
Patent Cooperation Treaty
PCT/CN11/074203
Filed on 2011-05-17

A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1

  • Read more about A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1
Australia
2011203056
Filed on 2004-12-10

Identification Of A Novel BHD Gene

  • Read more about Identification Of A Novel BHD Gene
US Patent 8,865,880
Filed on 2011-07-11

T-Cell Receptors and Related Materials and Methods of Use

  • Read more about T-Cell Receptors and Related Materials and Methods of Use
US Patent 8,785,601
Filed on 2010-01-25

Photosensitizing Antibody-Fluorophore Conjugates

  • Read more about Photosensitizing Antibody-Fluorophore Conjugates
US Patent 8,524,239
Filed on 2011-07-11

Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy

  • Read more about Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
US Patent 8,287,857
Filed on 2011-07-08

Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers

  • Read more about Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers
China
201010176288.X
Filed on 2011-05-17

Chromosome 3p21.3 Genes Are Tumor Suppressors

  • Read more about Chromosome 3p21.3 Genes Are Tumor Suppressors
US Patent 9,944,951
Filed on 2011-05-24

Customizable Specimen Evaluation

  • Read more about Customizable Specimen Evaluation
US Application 13/102,133
Filed on 2011-05-06

METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA

  • Read more about METHODS OF DETERMINING THE PROGNOSIS OF AN ADENOCARCINOMA
Italy
07799622.1
Filed on 2007-07-16

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 766
  • Page 767
  • Page 768
  • Page 769
  • Page 770
  • Page 771
  • Page 772
  • Page 773
  • Page 774
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health